Search research articles
Contact Us
Filters
Showing results (41-50 of 83) with videos related to
Page
of 9
Sort By:
Journal of Viral Hepatitis
|
September 19, 2007
Safety and efficacy of an induction dose of pegylated interferon alpha-2a on early hepatitis C virus kinetics in HIV/HCV co-infected patients: the CORAL-1 multicentre pilot study
C Tural, R Solà, R Rubio, et al.
Transplantation Proceedings
|
April 18, 2002
Are there differences in renal posttransplant evolution between the first and the second recipient from the same donor?
L L Guirado, M A Herreros, M Díaz, et al.
Transplantation Proceedings
|
January 3, 2006
Living donor renal transplantation in Catalonia: overall results and comparison of survival with cadaveric donor renal transplantation
R García-Maset, L Guirado Perich, E Vela Vallespin, et al.
Transplantation Proceedings
|
January 3, 2006
Factors involved in baseline hyperhomocysteinemia in renal transplantation
J M Díaz, Z Sainz, I Gich, et al.
Free Radical Biology & Medicine
|
January 1, 1997
Oleic acid rich diet protects against the oxidative modification of high density lipoprotein
R Solà, A E La Ville, J L Richard, et al.
Transplantation Proceedings
|
September 1, 2009
Prevalence evolution and impact of cardiovascular risk factors on allograft and renal transplant patient survival
J M Díaz, I Gich, X Bonfill, et al.
Alimentary Pharmacology & Therapeutics
|
April 16, 2013
Meta-analysis: pegylated interferon α-2a achieves higher early virological responses than α-2b in chronic hepatitis C
M Romero-Gómez, R Planas, J Ampuero, et al.
Transplantation Proceedings
|
September 10, 2003
Tacrolimus in induction immunosuppressive treatment in renal transplantation: comparison with cyclosporine
R Solà, J M Díaz, L Guirado, et al.
Transplantation Proceedings
|
January 3, 2006
Results and complications of 50 laparoscopic nephrectomies for live donor renal transplantation
L I Guirado, J M Díaz, C Facundo, et al.
Journal of Viral Hepatitis
|
September 15, 2011
Natural prevalence of HCV minority variants that are highly resistant to NS3/4A protease inhibitors
S Franco, R Bellido, E Aparicio, et al.
Page
of 9
Search research articles
Search
Showing results (41-50 of 83) with videos related to
Sort By:
Page
of 9
Journal of Viral Hepatitis
|
September 19, 2007
Safety and efficacy of an induction dose of pegylated interferon alpha-2a on early hepatitis C virus kinetics in HIV/HCV co-infected patients: the CORAL-1 multicentre pilot study
C Tural, R Solà, R Rubio, et al.
Transplantation Proceedings
|
April 18, 2002
Are there differences in renal posttransplant evolution between the first and the second recipient from the same donor?
L L Guirado, M A Herreros, M Díaz, et al.
Transplantation Proceedings
|
January 3, 2006
Living donor renal transplantation in Catalonia: overall results and comparison of survival with cadaveric donor renal transplantation
R García-Maset, L Guirado Perich, E Vela Vallespin, et al.
Transplantation Proceedings
|
January 3, 2006
Factors involved in baseline hyperhomocysteinemia in renal transplantation
J M Díaz, Z Sainz, I Gich, et al.
Free Radical Biology & Medicine
|
January 1, 1997
Oleic acid rich diet protects against the oxidative modification of high density lipoprotein
R Solà, A E La Ville, J L Richard, et al.
Transplantation Proceedings
|
September 1, 2009
Prevalence evolution and impact of cardiovascular risk factors on allograft and renal transplant patient survival
J M Díaz, I Gich, X Bonfill, et al.
Alimentary Pharmacology & Therapeutics
|
April 16, 2013
Meta-analysis: pegylated interferon α-2a achieves higher early virological responses than α-2b in chronic hepatitis C
M Romero-Gómez, R Planas, J Ampuero, et al.
Transplantation Proceedings
|
September 10, 2003
Tacrolimus in induction immunosuppressive treatment in renal transplantation: comparison with cyclosporine
R Solà, J M Díaz, L Guirado, et al.
Transplantation Proceedings
|
January 3, 2006
Results and complications of 50 laparoscopic nephrectomies for live donor renal transplantation
L I Guirado, J M Díaz, C Facundo, et al.
Journal of Viral Hepatitis
|
September 15, 2011
Natural prevalence of HCV minority variants that are highly resistant to NS3/4A protease inhibitors
S Franco, R Bellido, E Aparicio, et al.
Page
of 9